FDA NDC Directory · JSON-LD · Markdown

Portrazza

NDC 0002-7716 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namenecitumumab
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA125547
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsNECITUMUMAB (16 mg/mL)
Marketing started20151124
Marketing ended20260527
Package count1

External sources

Source: openFDA. Public-domain (CC0).